We found that pro-inflammatory markers such as IL-6 (at 24 h) and hematological markers such as NLR (at 24 and 72 h, respectively) were independent predictors of 28-day mortality in patients with severe COVID-19 living at high altitude in a low-resource setting. This evidence concerns the gene IL6 and COVID-19.